Static respiratory system compliance (Crs) 
Several trials have demonstrated that early use of surfactant in infants judged at high risk of respiratory distress syndrome is more effective than a policy of 'rescue' treatment of infants with established respiratory distress syndrome. [1] [2] [3] However, surfactant is expensive and the financial implications of its wider use will inevitably attract careful scrutiny. Furthermore, in infants who do not need it surfactant might be hazardous. Rapid and reliable methods for selecting infants at high risk of respiratory distress syndrome would be valuable if they could reduce the number of infants treated early unnecessarily without overall loss of clinical benefit.4 D'Costa et al predicted respiratory distress syndrome with 100% sensitivity and 93% specificity in 115 intubated infants with a laboratory assay using high performance liquid chromatography to measure lecithin/ sphingomyelin (U/S) ratios in tracheal aspirates.5 Unfortunately a postnatal assay for U/S ratio would be too slow to assist decisions about surfactant treatment in the first 2 hours of lifel 3 and prenatal assessment by amniocentesis is invasive and unlikely to be used routinely.
We therefore report a preliminary evaluation of static respiratory compliance (Crs) as a non-invasive, routine measurement to predict surfactant deficiency rapidly at the cotside.
Patients and methods

PATIENTS
Infants who were intubated at birth in two centres were eligible to have tracheal aspirates obtained and those still intubated on arrival in the neonatal intensive care unit were eligible for measurements of static Crs. As the passive expiratory flow technique is not applicable in infants with a continuous air leak through a pleural drain, infants who had a pneumothorax diagnosed and treated before lung function could be measured were excluded.
At accuracy of values of static Crs <1X8 ml/cm H20/m for surfactant deficiency was similar in the validation group: with sensitivity 94%, specificity 83%, positive predictive value 940/o, and negative predictive value 83%. In the 22 infants in the reference group, 9/9 with static Crs <1 8 ml/cm H20/m had radiological respiratory distress syndrome and 10/13 with static Crs 1 8 ml/m H20/m did not. Static Crs <1 8 ml/cm H20/m thus correctly classified the radiological diagnosis of respiratory distress syndrome in the first 8 hours with 75% sensitivity, 100% specificity, 100% positive predictive power, and 77% negative predictive power. As a comparison, in 48 infants at Dundee,9 26/34 with static Crs <1I 8 mb/cm H20/m had radiological respiratory distress syndrome and 9/14 with static Crs ¢ 1 8 mi/cm H20/m had not. Static Crs < 1-8 ml/cm H20/m was thus correlated with radiological respiratory distress syndrome in the first 8 hours with 84% sensitivity, 53% specificity, 76% positive predictive value, and 64% negative predictive value.
To determine whether it was more appropriate to correct static Crs values for length than for birth weight the sets of infants from the two centres were first combined and the accuracy of each correction compared (fig 2) . Values of static Crs corrected for length below 1 8 mbcm H20/m correctly classified surfactant deficiency with 93% sensitivity, 94% specificity, 96% positive predictive value, and 89% negative predictive value. The optimal cut off value for static Crs corrected for weight was <0 54 ml/cm H20/kg. This correctly classified surfactant deficiency with 89% sensitivity, 89% specificity, 92% positive predictive value, and 84% negative predictive value. Considering all possible cut offs for each method of correction, the area under the ROC curve was marginally greater for static Crs corrected for length (0-9568) than for static Crs corrected for weight (0 9506). How practicable would it be to measure static Crs routinely? The level of expertise required to perform and interpret static Crs measurements is similar to that required for cerebral ultrasound scanning, while the cost of the equipment is about one tenth. Measurements of static Crs usually take less than 10 minutes and could be performed within an hour of birth by clinical staff with suitable training. Further evaluation of the technique in other centres is now needed. If that proved encouraging, the next step would be to organise a multicentre trial to test whether, compared with conventional management, routine measurement of static Crs in mechanically ventilated infants can reduce the use of surfactant while simultaneously reducing or causing no increase in the risk of major adverse clinical events. Such a trial need not be prohibitively large. For example, 400 infants per group would be sufficient to demonstrate a difference in major adverse events from 40% to 30% with over 80% power at conventional statistical significance (2p=0 05).
